SCHEMBL13664237

SCHEMBL13664237

CCOC(=O)C(OC)=C(C#N)C#N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
TSHR P16473 1/20 0.52
CYP2C9 P11712 1/20 0.44
KDM4E B2RXH2 4/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPSR1 Q6W5P4 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 3/20 0.38
MGAM O43451 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
DHODH Q02127 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
PKM P14618 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24014846 0.81 ALDH1A1 (0.48) ALDH1A1TSHRCYP2C9KDM4EMAPT
SCHEMBL14776464 0.77 ALDH1A1 (0.57) ALDH1A1TSHRCYP2C9KDM4EMAPT
SCHEMBL9978312 0.75 ALDH1A1 (0.55) ALDH1A1TSHRCYP2C9KDM4EMAPT
SCHEMBL13664238 0.75 ALDH1A1 (0.55) ALDH1A1TSHRCYP2C9KDM4EMAPT
SCHEMBL17317995 0.73 ALDH1A1 (0.53) ALDH1A1TSHRCYP2C9KDM4EMAPT
SCHEMBL4174829 0.72 MAPT (0.44) ALDH1A1TSHRKDM4EMAPTMEN1
SCHEMBL31277508 0.72 ALDH1A1 (0.52) ALDH1A1TSHRCYP2C9KDM4EMAPT
SCHEMBL10872877 0.72
SCHEMBL2115865 0.72 ALDH1A1 (0.61) ALDH1A1TSHRCYP2C9KDM4EMAPT
SCHEMBL1754710 0.72 ALDH1A1 (0.61) ALDH1A1TSHRCYP2C9KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720067-A1 BICYCLIC HETEROARYLAMIDES HAVING GPR68 MODULATING ACTIVITY Recursion Pharmaceuticals, Inc. (US) 2026-04-08 EP disclosed
WO-2024246559-A1 BICYCLIC HETEROARYLAMIDES HAVING GPR68 MODULATING ACTIVITY EXSCIENTIA AI LIMITED (GB) 2024-12-05 WO disclosed
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists GIPR, GPR119, GLP1R ALDH1A1 3415/4885TSHR 70/4885CYP2C9 2168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.